Evidence map›Paper›PMID 37862240›Full record

SynthesisJNCI cancer spectrum2023

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.

Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding and 75 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in JNCI cancer spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. To trust or not to trust: evaluating the reliability and safety of AI responses to laryngeal cancer queries.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

85 authors at 20 institutions in 11 countries.

Elnaz NaderiDepartment of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0003-1671-7471
Miguel E Aguado-BarreraFundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.
Line M H SchackDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Leila DorlingCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Tim RattayLeicester Cancer Research Centre, University of Leicester, Leicester, UK.
Laura FachalWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Holly SummersgillManchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
Laura Martínez-CalvoFundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.
Ceilidh WelshDepartment of Oncology, University of Cambridge, Cambridge, UK.
Tom DuddingBristol Dental School, University of Bristol, Bristol, UK.
Yasmin OddingBristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Ana Varela-PazosDepartment of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
Rajesh JenaDepartment of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
David J ThomsonDivision of Cancer Sciences, University of Manchester, Manchester, UK.
Roel J H M SteenbakkersDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Joe DennisCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4591-1214
Ramón Lobato-BustoDepartment of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
Jan AlsnerDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Andy NessBristol Dental School, University of Bristol, Bristol, UK.
Chris NuttingHead and Neck Unit, The Royal Marsden Hospital, London, UK.
Antonio Gómez-CaamañoInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Jesper G EriksenDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Steve J ThomasBristol Dental School, University of Bristol, Bristol, UK.
Amy M BatesDepartment of Oncology, University of Cambridge, Cambridge, UK.
Adam J WebbDepartment of Genetics and Genome Biology, University of Leicester, Leicester, UK.
Ananya ChoudhuryDivision of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
Barry S RosensteinDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Begona Taboada-ValladaresInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Carsten HerskindDepartment of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
David AzriaFédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, ICM Montpellier, INSERM U1194 IRCM, University of Montpellier, Montpellier, France.
David P DearnaleyDivision of Radiotherapy and Imaging, The Institute of Cancer Research Department, The Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0002-3954-2806
Dirk de RuysscherMAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Elena SperkDepartment of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Emma HallClinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Hilary StobartPatient Advocate, Independent Cancer Patients' Voice, London, UK.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Kim De RuyckDepartments of Basic Medical Sciences and Radiotherapy, Ghent University Hospital, Ghent, Belgium.
Liv VeldemanDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Manuel AltabasRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Maria Carmen De SantisRadiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Marie-Pierre Farcy-JacquetFédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, CHU Carémeau, Nîmes, France.
Marlon R VeldwijkDepartment of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Matthew R SydesMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Matthew ParliamentDivision of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Nawaid UsmaniDivision of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Neil G BurnetThe Christie NHS Foundation Trust, Manchester, UK.
Petra SeiboldDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
R Paul SymondsCancer Research Centre, University of Leicester, Leicester, UK.
Rebecca M ElliottDivision of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
Renée BultijnckDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Sara Gutiérrez-EnríquezHereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.
Meritxell MollàRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Sarah L GullifordDepartment of Medical Physics and Biomedical Engineering, University College London, UK.
Sheryl GreenDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Tiziana RancatiData Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Victoria ReyesRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ana CarballoInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Paula PeleteiroInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Paloma Sosa-FajardoInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Chris ParkerDepartment of Medical Physics and Biomedical Engineering, University College London, UK.ORCID 0000-0001-6512-124X
Valérie FonteyneDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
Kerstie JohnsonLeicester Cancer Research Centre, University of Leicester, Leicester, UK.
Maarten LambrechtRadiation Oncology, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8746-2691
Ben VannesteDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Riccardo ValdagniRadiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID 0000-0002-7849-603X
Alexandra GiraldoRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Mónica RamosRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Brenda DiergaardeDepartment of Human Genetics, School of Public Health, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Geoffrey LiuPrincess Margaret Cancer Centre, Temerty Faculty of Medicine, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-2603-7296
Suzanne M LealCenter for Statistical Genetics, Gertrude H. Sergievsky Center, and the Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Melvin L K ChuaDivision of Radiation Oncology, National Cancer Centre Singapore, Singapore.
Miranda PringBristol Dental School, University of Bristol, Bristol, UK.
Jens OvergaardDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-0814-8179
Luis M Cascallar-CanedaDepartment of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
Fréderic DuprezDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Christopher J TalbotDepartment of Genetics and Genome Biology, University of Leicester, Leicester, UK.
Gillian C BarnettDepartment of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1762-5942
Alison M DunningCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Ana VegaFundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.ORCID 0000-0002-7416-5137
Christian Nicolaj AndreassenDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Johannes A LangendijkDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Catharine M L WestTranslational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
Behrooz Z AlizadehDepartment of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.
Sarah L KernsDepartment of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0002-6503-0011
Radiogenomics Consortium
Complejo Hospitalario Universitario de Santiago · ESUniversity of Cambridge · GBGhent University Hospital · BEVall d'Hebron Hospital Universitari · ESUniversity of Leicester · GBAarhus University Hospital · DKManchester Academic Health Science Centre · GBUniversity Medical Center Groningen · NLUniversity Of Bristol Dental Hospital · GBFondazione IRCCS Istituto Nazionale dei Tumori · ITHeidelberg University · DERoyal Marsden NHS Foundation Trust · GBFundación Pública Galega de Medicina Xenómica · ESIcahn School of Medicine at Mount Sinai · USUniversity of Alberta · CAUniversity of Manchester · GBColumbia University Irving Medical Center · USDuke-NUS Medical School · SGGerman Cancer Research Center · DEInserm · FR

Funding

Cancer Research UK 25351Wellcome Trust
6 · The paper itself

Abstract

backgroundThis study was designed to identify common genetic susceptibility and shared genetic variants associated with acute radiation-induced toxicity across 4 cancer types (prostate, head and neck, breast, and lung).

methodsA genome-wide association study meta-analysis was performed using 19 cohorts totaling 12 042 patients. Acute standardized total average toxicity (STATacute) was modelled using a generalized linear regression model for additive effect of genetic variants, adjusted for demographic and clinical covariates (rSTATacute). Linkage disequilibrium score regression estimated shared single-nucleotide variation (SNV-formerly SNP)-based heritability of rSTATacute in all patients and for each cancer type.

resultsShared SNV-based heritability of STATacute among all cancer types was estimated at 10% (SE = 0.02) and was higher for prostate (17%, SE = 0.07), head and neck (27%, SE = 0.09), and breast (16%, SE = 0.09) cancers. We identified 130 suggestive associated SNVs with rSTATacute (5.0 × 10‒8 < P < 1.0 × 10‒5) across 25 genomic regions. rs142667902 showed the strongest association (effect allele A; effect size ‒0.17; P = 1.7 × 10‒7), which is located near DPPA4, encoding a protein involved in pluripotency in stem cells, which are essential for repair of radiation-induced tissue injury. Gene-set enrichment analysis identified 'RNA splicing via endonucleolytic cleavage and ligation' (P = 5.1 × 10‒6, P = .079 corrected) as the top gene set associated with rSTATacute among all patients. In silico gene expression analysis showed that the genes associated with rSTATacute were statistically significantly up-regulated in skin (not sun exposed P = .004 corrected; sun exposed P = .026 corrected).

conclusionsThere is shared SNV-based heritability for acute radiation-induced toxicity across and within individual cancer sites. Future meta-genome-wide association studies among large radiation therapy patient cohorts are worthwhile to identify the common causal variants for acute radiotoxicity across cancer types.

Indexed as

Genome-Wide Association StudyNeoplasmsBreastGenetic Predisposition to DiseaseHumansMale

Identifiers

PMID37862240
PMCPMC10653584
OpenAlexW4387805440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.